Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Fig. 2

List and incidence of AGAs. The top 35 AGAs identified in more than 1% of 441 exploitable samples are ordered from top to bottom according to the decreasing percentage of altered patients in the whole population with exploitable profile (% to the right of color matrix). The cancer types are ordered from left to right according to the number of samples with alterations for those 35 AGAs. The percentage of patients with each AGA per cancer type is color-coded as indicated to the right of matrix

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us